Stanford Report, October 25, 2000
|Medical Center faculty
appointment and promotion announced
BY JOYCE THOMAS
The following medical faculty have been promoted or appointed: Deborah Alcorn, MD, has received a promotion at Stanford University Medical Center and Lucile Packard Children's Hospital, and Robert S. Fisher, MD, PhD, has joined the Stanford University Medical Center faculty.
Alcorn has been promoted to associate professor of ophthalmology and of pediatrics at Stanford and Packard effective September 2000 through August 2005. Alcorn received her medical degree in 1981 from the University of Iowa College of Medicine. She completed a residency in ophthalmology at the Medical College of Wisconsin and a fellowship in pediatric ophthalmology at Indiana University, as well as a two-year fellowship in ocular genetics at the Wilmer Ophthalmological Institute at Johns Hopkins.
Alcorn joined Stanford in 1991. Her clinical responsibilities include evaluating general pediatric ophthalmology patients and participating in multidisciplinary clinics for children with genetic disorders. She directs the ophthalmic genetics section of Stanford's basic science course in ophthalmology. Alcorn, whose expertise focuses on the delineation of the ophthalmic manifestations of genetic disorders in children and adults, is exceptional as one of the few ophthalmic geneticists in North America.
Fisher has been appointed to the Medical Center faculty as professor of neurology and neurological sciences effective September 2000 through August 2005. He received his PhD in neurological sciences in 1976 and his MD in 1977, both from Stanford. From 1983 through 1991 Fisher served on the faculty at Johns Hopkins University, where he achieved the rank of associate professor. In 1992 he moved to the Barrow Neurological Institute, Phoenix, Ariz., where he chaired the Department of Neurology and served as chief of the Epilepsy Center and neurophysiology before returning to Stanford this fall.
Fisher will direct
Stanford's Comprehensive Epilepsy Center. He is an active
investigator in basic clinical neurophysiology/pharmacology and in
clinical neurology. His work focuses on the neurophysiological
mechanisms of seizures and the development of new methods to treat
epilepsy. He has served as president of the American Epilepsy
Society, as associate editor of Epilepsia, and on the National
Executive Committee of the Epilepsy Foundation of America.